Mid-term results for second-generation thoracic stent grafts

• DOI: 10.1002/bjs.4178
• Publication Date: 2003-07-07T10:05:01Z
• Authors: R E Bell; P R Taylor; M Aukett; T Sabharwal; J F Reidy
• Keywords: Paraplegia; Thoracic aorta; Cardiothoracic surgery; Thoracic aortic aneurysm; Stroke

Abstract Background Thoracic stent grafts offer an alternative to open surgery for thoracic aortic disease, but their long-term durability is unknown. This report includes mid-term follow-up commercially available devices. Methods Data were collected prospectively a series of endoluminal used treat pathology. Results Between July 1997 and October 2002, 67 patients received grafts. Elective procedures incurred 30-day mortality rate 2 per cent (one 42 patients) urgent repair 16 (four 25). Paraplegia affected three (4 cent) had stroke. The median was 17 (range 2–64) months; four lost. There six late deaths, two from aneurysm rupture (rupture mycotic at 5 months migration 28 months). Other device-related complications comprised proximal endoleaks, one which required surgical correction with removal the graft, distal successfully treated extension cuffs. Conclusion In mid term, pathology appears be safe surgery, continued surveillance essential.